dr. boorjian on research with nadofaragene firadenovec in nonmuscle invasive bladder cancer
Published 4 years ago • 463 plays • Length 1:19Download video MP4
Download video MP3
Similar videos
-
1:12
scott tagawa, md, on the study investigating nadofaragene firadenovec in bcg unresponsive nmibc
-
0:40
nadofaragene firadenovec shows durable responses in nmibc
-
1:29
dr. bajorin on chemotherapy approaches in bladder cancer
-
1:33
dr. balar on results of durvalumab plus tremelimumab in bladder cancer
-
1:08
dr. rafii on durvaluamb in patients with urothelial bladder cancer
-
1:50
dr. powles on the current state of research in bladder cancer
-
4:52
bladder cancer: immunotherapy in the perioperative setting
-
33:52
know the symptoms of bladder cancer
-
32:30
bladder cancer and immunotherapy with dr. terence friedlander
-
11:04
bladder cancer - overview (types, pathophysiology, diagnosis, treatment)
-
4:20
switch maintenance strategy for metastatic bladder cancer
-
1:28
dr. flaig on immune checkpoint inhibitors in advanced bladder cancer
-
1:33
dr. gupta on challenges with perioperative immunotherapy in bladder cancers
-
1:07
dr. balar on impact of durvalumab plus tremelimumab in bladder cancer
-
1:32
dr. balar discusses study of immunotherapy combination in bladder cancer
-
4:46
the future of bladder cancer research
-
0:45
copy of dr. balar on next steps of the keynote-057 trial in nmibc
-
7:41
bcg-refractory superficial bladder cancer
-
1:21
dr. rosenberg on immunotherapeutic advances in bladder cancer
-
6:42
adjuvant pembrolizumab: the ambassador trial - bladder cancer video library
-
0:43
dr. rosenberg discusses the importance of clinical trials in bladder cancer
-
2:35
resect: variation in quality of turbt and its impact on bladder cancer management